Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 32.90
-0.15 (-0.45%)
Jan 22, 2026, 1:10 PM CST
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 4.12 billion as of January 21, 2026. Its market cap has decreased by -53.68% in one year.
Market Cap
4.12B
Enterprise Value
4.14B
Revenue
588.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.90
Market Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 4.12B, an increase of 821.10%. That is a compound annual growth rate of 12.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 4.22B | -5.45% |
| Dec 31, 2025 | 4.46B | -43.03% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 7.05B |
| Orient Pharma | 6.56B |
| SCI Pharmtech | 6.35B |
| Mercury Biopharmaceutical | 4.21B |
| Orient EuroPharma | 3.87B |
| Maywufa Company | 2.91B |
| Golden Biotechnology | 2.90B |
| PhytoHealth | 2.76B |